Named as a key player in 66 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Over The Counter (OTC) Analgesics | OTC & Nutraceuticals | $22 Bn | 3.4% |
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
Named as key players in the same markets as Takeda Pharmaceutical COmpany Limited (number of shared markets).
AstraZeneca2 shared markets
Bayer AG2 shared markets
GSK PLC2 shared markets
Johnson & Johnson2 shared markets
Reckitt Benckiser Group PLC2 shared markets
Sanofi2 shared markets
AbbVie Inc.1 shared market
Bausch Health1 shared market
Search all reports for Takeda Pharmaceutical COmpany Limited All companies